Harmony Biosciences Holdings, Inc. (HRMY)
38.51
+0.36
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
38.51
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings EPS Diluted (Quarterly) : 1.284 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.284 |
| March 31, 2026 | 0.5527 |
| December 31, 2025 | 0.3831 |
| September 30, 2025 | 0.8663 |
| June 30, 2025 | 0.6808 |
| March 31, 2025 | 0.7785 |
| December 31, 2024 | 0.8498 |
| September 30, 2024 | 0.7933 |
| June 30, 2024 | 0.2014 |
| March 31, 2024 | 0.6656 |
| December 31, 2023 | 0.4521 |
| September 30, 2023 | 0.6338 |
| June 30, 2023 | 0.5647 |
| March 31, 2023 | 0.4816 |
| December 31, 2022 | 0.7872 |
| Date | Value |
|---|---|
| September 30, 2022 | 1.437 |
| June 30, 2022 | 0.3862 |
| March 31, 2022 | 0.3546 |
| December 31, 2021 | 0.3766 |
| September 30, 2021 | -0.1667 |
| June 30, 2021 | 0.2409 |
| March 31, 2021 | 0.1256 |
| December 31, 2020 | -0.0037 |
| September 30, 2020 | -0.0721 |
| June 30, 2020 | -0.1645 |
| March 31, 2020 | -0.7705 |
| December 31, 2019 | -0.8089 |
| September 30, 2019 | -0.7194 |
| June 30, 2019 | -0.4543 |
| March 31, 2019 | -1.120 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Liquidia Corp. | 0.7369 |
| Repligen Corp. | 0.0884 |
| Johnson & Johnson | 2.268 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| ANI Pharmaceuticals, Inc. | 1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 75.43M |
| Revenue (Quarterly) | 261.28M |
| Total Expenses (Quarterly) | 185.85M |
| Enterprise Value | 1.770B |
| Gross Profit Margin (Quarterly) | 73.53% |
| Profit Margin (Quarterly) | 28.87% |
| Earnings Yield | 8.01% |
| Operating Earnings Yield | 10.20% |
| Normalized Earnings Yield | 8.013 |